Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety

SS O'Malley, WR Corbin, RF Leeman… - The Journal of clinical …, 2015 - psychiatrist.com
Objective: Naltrexone, an opioid antagonist, may facilitate reduction in drinking among
young adults. We compared the efficacy and safety of naltrexone administered daily plus …
被引用次数：77 相关文章
[PDF] academia.edu

[PDF][PDF] Focus on Addiction Reduction of Alcohol Drinking in Young Adults by Naltrexone: A Double-Blind, Placebo-Controlled, Randomized

SS O'Malley, WR Corbin, RF Leeman… - J Clin …, 2015 - academia.edu
Objective: Naltrexone, an opioid antagonist, may facilitate reduction in drinking among
young adults. We compared the efficacy and safety of naltrexone administered daily plus …
[HTML] nih.gov

[HTML][HTML] Reduction of Alcohol Drinking in Young Adults by Naltrexone: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety

SS O'Malley, WR Corbin, RF Leeman… - The Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Objective Naltrexone, an opioid antagonist, may facilitate reduction in drinking among young
adults. We compared the efficacy and safety of naltrexone administered daily plus targeted …

Reduction of alcohol drinking in young adults by naltrexone: A double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.

SS O'Malley, WR Corbin, RF Leeman… - The Journal of …, 2015 - psycnet.apa.org
Objective: Naltrexone, an opioid antagonist, may facilitate reduction in drinking among
young adults. We compared the efficacy and safety of naltrexone administered daily plus …

Reduction of alcohol drinking in young adults by naltrexone: A double-blind, placebo-controlled, randomized clinical trial of efficacy and safety

SS O'Malley, W Corbin, RF Leeman… - Journal of Clinical …, 2015 - asu.elsevierpure.com
Objective: Naltrexone, an opioid antagonist, may facilitate reduction in drinking among
young adults. We compared the efficacy and safety of naltrexone administered daily plus …

Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety

SS O'Malley, WR Corbin, RF Leeman, KS DeMartini… - 2015 - pubmed.ncbi.nlm.nih.gov
Objective Naltrexone, an opioid antagonist, may facilitate reduction in drinking among young
adults. We compared the efficacy and safety of naltrexone administered daily plus targeted …

Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.

SS O'Malley, WR Corbin, RF Leeman… - The Journal of …, 2015 - europepmc.org
Objective Naltrexone, an opioid antagonist, may facilitate reduction in drinking among young
adults. We compared the efficacy and safety of naltrexone administered daily plus targeted …

Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.

SS O'Malley, WR Corbin, RF Leeman… - The Journal of …, 2015 - europepmc.org
Objective Naltrexone, an opioid antagonist, may facilitate reduction in drinking among young
adults. We compared the efficacy and safety of naltrexone administered daily plus targeted …

[引用][C] Focus on Addiction Reduction of Alcohol Drinking in Young Adults by Naltrexone: A Double-Blind, Placebo-Controlled, Randomized

SS O'Malley, WR Corbin, RF Leeman, KS DeMartini… - J Clin Psychiatry, 2015